Drive the execution of therapy plans through a team of 4-5 Therapy Managers within the assigned geography and therapy with the objective of achieving business goals

Accountabilities

I. Own the Sales Planning Achievement for respective geography for assigned therapy to ensure 100% budget achievement through his / her team

II. Control monitor business results and performance of all team members to ensure no SOP deviation and optimum performance of the team

III. Manage external Stakeholders to ensure ongoing business results

IV. Own spotting and referrals of potential candidates and Induction of new joinees as well as engagement of existing team members

V. Drive performance management team development to increase effectiveness that will yield better on-field results

Education Qualification

B.Sc./B.Pharm

Relevant Work Experience

3 - 4 years of experience as a sales team leader in the pharmaceutical industry

Competencies/Skills

Collaborate to Succeed

Innovate to Excel

Perform with Accountability

Lead with Empathy

Act with Agility

Strong Domain Knowledge

People Management

Job Location

Bangalore

Shift Hours

Role: Zonal Sales Manager (B2C)

Industry Type: Pharmaceutical & Life Sciences

Department: Sales & Business Development

Employment Type: Full Time, Permanent

Role Category: Retail & B2C Sales

Education

UG: Any Graduate

PG: Any Postgraduate

About company

Cipla is a global pharmaceutical company which uses cutting edge technology and innovation to meet the everyday needs of all patients. For over 80 years, Cipla has emerged as one of the most respected pharmaceutical names in India as well as across more than 100 countries. Our portfolio includes over 1000 products across wide range of therapeutic categories with one quality standard globally.

Whilst delivering a long-term sustainable business, Cipla recognises its duty to provide affordable medicines. Ciplas emphasis on access for patients was recognised globally for the pioneering role played in HIV/AIDS treatment as the first pharmaceutical company to provide a triple combination anti-retroviral (ARV) in Africa at less than a dollar a day and thereby treating many millions of patients since 2001.